The Pharmaceutical Development and Bioavailability of Cimetidine Capsule and Tablet Formulations
- 1 January 1979
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 5 (2) , 217-226
- https://doi.org/10.3109/03639047909055672
Abstract
The development of a suitable oral solid dosage form of cimetidine has been examined from the standpoint of equal bioavailability for different formulations. The in vitro characteristics of one capsule and four tablet formulations were determined. From the areas under the blood level/time curves in healthy volunteers, equal bioavailability was shown between the capsule, the original tablet formulation chosen for early clinical trials and the final tablet formulation used for commercial production.This publication has 4 references indexed in Scilit:
- High-Pressure Liquid Chromatographic Analysis of Cimetidine, a Histamine H2-Heceptor Antagonist, in Blood and UrineJournal of Pharmaceutical Sciences, 1977
- Inhibition of Gastric Acid Secretion by Cimetidine in Patients with Duodenal UlcerNew England Journal of Medicine, 1975
- Cimetidine—A Non-Thiourea H2-Receptor AntagonistJournal of International Medical Research, 1975
- The Preparation Of Compressed Tablets: Part III.—A Study of the Value of Potato Starch and Alginic Acid as Disintegrating AgentsJournal of Pharmacy and Pharmacology, 1950